Article
A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer.
BMC cancer - 6 Aug 2008
Narita Naofumi, Yuasa Takeshi, Tsuchiya Norihiko, Kumazawa Teruaki, Narita Shintaro, Inoue Takamitsu, Ma Zhiyong, Saito Mitsuru, Horikawa Yohei, Satoh Shigeru, Ogawa Osamu, Habuchi Tomonori
Abstract excerpt
BACKGROUND: The purpose of this study was to evaluate the role of osteoprotegerin gene (OPG) polymorphisms as genetic modifiers in the etiology of prostate cancer (PCa) and disease progression. METHODS: Three hundred and sixty one patients with PCa and 195 normal controls were enrolled in the study, and two genetic polymorphisms, 149 T/C and 950 T/C in the putative promoter region of OPG, were genotyped. RESULTS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
